DUBLIN, Sept. 6, 2018 /PRNewswire/ --
The "Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 - 2024" report has been added to ResearchAndMarkets.com's offering.
The global pharmacovigilance and drug safety software market size is expected to reach USD 207.7 million by 2024, presenting a CAGR of 6.5% during the forecast period.
Increasing number of adverse drug reactions (ADR) is a key factor for market growth. ADR imposes a significant burden on research organizations and companies. To curb this problem, pharmaceutical companies are opting for contract outsourcing of these services.
Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in short as well as long terms. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes.
PV service providers, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These firms are also incorporating integrated technologies such as electronic data capture and hosting of PV warehousing for aggregating cross industry data for benefit risk evaluation. Furthermore, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period.
Further key findings from the report suggest:
- By functionality, fully integrated software solutions for pharmacovigilance are anticipated to reach USD 25.35 million by 2024, at a CAGR of 7.0% from 2016 to 2024. The ADR reporting software segment, on the other hand, is projected to ascend at a CAGR of 6.4% over the forecast period
- Based on delivery mode, the on-demand segment dominated the global pharmacovigilance software market with a share of over 52.0% in 2015
- On the basis of end use, the CROs and BPO segments are slated to witness lucrative growth owing to increasing adoption by outsourcing companies to curb healthcare costs
- The U.S. PV software market is anticipated to exceed USD 6.45 million by 2024. Asian countries, especially India and China, are also expected to observe remarkable growth in the coming years
- The market is relatively competitive in nature thanks to presence of global multinational players. It is also consolidated to a certain extent
Key Topics Covered:
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.2 Region Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends& Scope
4.1 Market Segmentation & Scope
4.1.1 Market driver analysis
4.1.1.1 Rising incidences of ADR
4.1.1.2 Globalization of pharmacovigilance
4.1.1.3 Increasing burden from regulatory authorities
4.1.1.4 Introduction of technologically advanced software services
4.1.2 Market restraint analysis
4.1.2.1 Expensive technology
4.2 Penetration & Growth Prospect Mapping
4.3 Pharmacovigilance & Drug Safety Software- PESTLE Analysis
4.4 Industry Analysis - Porter's
Chapter 5 Functionality Estimates & Trend Analysis
5.1 Pharmacovigilance & Drug Safety Software Market: Functionality Movement Analysis
5.2 ADR Reporting Software
5.3 Drug Safety Audits
5.4 Issue Tracking
5.5 Fully Integrated Software
Chapter 6 Delivery Mode Estimates & Trend Analysis
6.1 Pharmacovigilance & Drug Safety Software Market: Delivery Mode Movement Analysis
6.2 On-premise
6.3 On-demand
Chapter 7 End-use Estimates & Trend Analysis
7.1 Pharmacovigilance & Drug Safety Software Market: End-use Movement Analysis
7.2 Pharma & Biotech Companies
7.3 CROs
7.4 BPOs
7.5 Others
Chapter 8 Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use
Chapter 9 Competitive Landscape
- AB cube
- Max Application
- Ennov Solutions, Inc.
- ArisGlobal
- EXTEDO GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sparta Systems, Inc.
- United BioSource Corporation
- Relsys
For more information about this report visit
https://www.researchandmarkets.com/research/cqz8xf/global?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article